Insulin binding and 2-deoxy-d-glucose uptake were compared in the soleus, plantaris, and extensor digitorum longus (EDL) muscles, in vitro, since the known biochemical profile of the soleus differs markedly from the other two. The present study showed that insulin binding increased in all three muscles with increasing concentrations of insulin in the range of 0.2-30 nM. However, the increase in binding of insulin to soleus at each insulin concentration exceeded that observed in the other two muscles (P < 0.05). Differences between the plantaris and EDL were not significant. The quantity of insulin bound at each concentration also increased more rapidly in the soleus than in either the plantaris (P < 0.05) or EDL (P < 0.05). Basal and insulin-stimulated uptake of 2-deoxy-d-glucose was also greater in the soleus than in the other muscles (P < 0.05). Maximal 2-deoxy-d-glucose uptake occurred at 1 nM insulin in each of the three muscles. These results indicate that in metabolically distinct types of skeletal muscles glucose uptake can differ markedly, and this is related to differences in the insulin binding capacities of these muscles. DIABETES 30:702-704, August 1981. S keletal muscle is an important target site for insulin since it represents 40-45% of total body weight and glucose is one of its major substrates. It is now possible to relate binding to glucose uptake and utilization in intact skeletal muscle in vitro.
fasted mice. 2 In ob/ob mice, insulin sensitivity of the soleus muscle is decreased as are 2-deoxy-d-glucose uptake, glycolysis, and glycogenesis.
1 " 3 These results differ from observations in adipocytes where postreceptor biologic responses to insulin remain depressed even when insulin binding is increased. 4 - 5 Consequently, the results from experiments with adipocytes should not be generalized to include events in skeletal muscle.
A similar caution, however, may also be necessary for different types of skeletal muscle, since this tissue is metabolically heterogeneous. In rodents, three metabolically distinct types of muscle fibers have been classified. These are known as fast-twitch glycolytic (FG), fast-twitch-oxidativeglycolytic (FOG), and slow-twitch oxidative (SO). 6 The fasttwitch (FG and FOG) and slow-twitch fibers (SO) differ markedly in their physiologic contractile properties, 7 and the FOG, FG, and SO have unique biochemical profiles 8 -9 that predispose them to glycolysis and/or oxidative metabolism. These distinct metabolic characteristics suggest that their preference for carbohydrate or lipid metabolism may also be quite different.
Soleus muscle is composed primarily of SO fibers (> 80%) 10 whereas such other hindlimb muscles as the plantaris and extensor digitorum longus (EDL) consist primarily of FG and FOG fibers in rodents. 10 Such intact muscles are commonly taken to be highly representative of specific muscle fibers without isolating the individual fibers.
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Several reports indicate that metabolically distinct types of skeletal muscle exhibit different responses to insulin. For example, (1) protein synthesis is impaired by the lack of insulin in fast-twitch muscle, whereas slow twitch muscle (soleus) showed little such impairment, (2) in streptozotocin-diabetic rats, phosphofructokinase and succinate dehydrogenase activities are uniquely reduced in different muscles, 12 and (3) insulin-stimulated glucose metabolism in the EDL is only 50-80% when compared with soleus muscle. 15 These data suggest the possibility that different types of skeletal muscle have different insulin binding capacities. Indeed, a brief communication from this laboratory has noted that the insulin binding capacities of the plantaris muscle is only 54% of that found in the soleus at a low level of insulin (0.2 nM). 16 In the present studies, we have extended these observations to include (1) the differences in insulin binding capacities of soleus, plantaris, and EDL, and (2) the differences in 2-deoxy-d-glucose uptake in the same muscles, over a wide range of insulin concentrations (0-30 nM).
MATERIAL AND METHODS
Swiss-Webster mice (male) (30-40 g) were anesthetized (sodium pentabarbital 100 mg/kg, i.p.), and the soleus, plantaris, and EDL were removed intact and mounted on a small clip tied at the tendons. Preincubation and incubation of the muscles were performed as described by LeMarchand et al. 1 -2 Incubations were continued for 4 h with 125 l-insulin (0.2 nM) (S.A. 100/xCi//u,g), and varying concentrations of porcine monocomponent insulin (gift from Dr. M. Root, Eli Lilly Co., Indianapolis, Indiana). Nonspecific binding (NSB) was determined in the presence of 7500 nM of unlabeled insulin. At the end of the 4-h incubation period, 2-deoxy-dglucose (0.5 mM, 1 /tCi/vial) was added and the incubation was continued for exactly 15 min. Subsequently, the muscles were washed and digested as described previously.
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RESULTS
Insulin binding increased in each of the three muscles as the concentrations of cold insulin in the incubation medium were increased. In absolute terms, nonspecific binding (%binding/mg protein) was always slightly greater in the soleus (0.18 ± 0.09%/mg protein) than in the plantaris and EDL (0.11 ± 0.05%/mg protein) (P < 0.05). Total 125 L-insulin binding was always lower in the plantaris and EDL than in the soleus such that nonspecific binding in soleus represented less than 20% of the total binding capacity of this muscle, but 30% in the EDL and plantaris.
The quantity of insulin bound for a given insulin concentration was always greater in the soleus than in either the plantaris (P < 0.05) or the EDL (P < 0.05) at each concentration (Table 1 ). These differences did not simply remain parallel throughout the entire range of insulin concentrations. There was a more pronounced increase in insulin binding in the soleus with each insulin increment in the range of 0.2-30 nM.
The uptake of 2-deoxy-d-glucose was consistently greater in the soleus at basal and at the selected insulin concentrations (Table 2 ) when compared with the other two muscles (P < 0.05). In each muscle maximal insulin-stimulated glucose uptake occurred at approximately 1 nM of insulin.
DISCUSSION
These studies have shown that metabolically distinct types of skeletal muscle exhibit different capacities to bind insulin and to augment insulin-stimulated 2-deoxy-d-glucose uptake. Soleus muscle insulin binding and 2-deoxy-d-glucose transport were always greater than these parameters in the plantaris and EDL. The data support the observations that insulin-stimulated glucose uptake is greater in the soleus than in the EDL 15 The values observed here for insulin binding and 2-deoxy-d-glucose uptake in soleus are greater than those reported in other studies. 1i2> These differences may be related to the strain of mice used, the age of the animals, or the protein assay. In the studies by LeMarchand-Brustel et al., 1>2 such differences are also apparent between groups of Swiss albino mice and lean littermates of ob/ob mice 1 and between different groups of Swiss albino mice. 2 When data for ob/ob mice from different investigations are compared, very large differences in insulin binding are apparent. 
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INSULIN BINDING AND GLUCOSE UPTAKE IN RODENT SKELETAL MUSCLES uptake found. Finally, all the data are expressed relative to the total protein content of the muscles. The selection of the protein standard against which to evaluate the protein content of the muscle sample can therefore influence the calculated data of the parameters under investigation. In the present study, the protein determinations were made with the procedure described by Bradford 17 and a protein standard composed of human albumin and globulin. When bovine serum albumin is used as the standard in this same assay procedure, the calculated protein content of a sample is increased by a factor of 1.82. It may therefore be estimated that the insulin binding and 2-deoxy-d-glucose uptake would be reduced by this same factor if the protein content were determined from a BSA standard curve. With this transformation our insulin binding data and the 2-deoxy-d-glucose uptake in soleus muscle correspond more closely to that reported by LeMarchand-Brustel et al., 1 -2 who used human albumin with the Lowry protein determination. It should be remembered that protein determinations are not truly absolute since quantification of a procedure relies on the specific property of the protein rather than on the mass of protein. Thus, the fact that our binding data and 2-deoxyd-glucose uptake data in soleus muscle differ from other reports 1 -2 may be attributed to one or more of these foregoing factors.
The present results probably reflect true biologic differences in metabolically distinct skeletal muscles, since differences cannot be accounted for by different muscle weights (see Table 1 ). The reason for differences in insulin binding is unknown. One possibility would be that insulin is distributed less effectively throughout the EDL and plantaris, since the capillary/fiber ratio is lower in these muscles than in the soleus. 18 Thus, in vivo, direct access of insulin from the circulation to the insulin receptor might be reduced. However, our preliminary experiments indicated that the 4-h incubation period in vitro in the soleus and plantaris was sufficient to permit steady-state binding, suggesting that binding equilibrium throughout the muscles had been attained, making this explanation unlikely.
We discount the notion that the plantaris or EDL store more insulin than the soleus, which might thus reduce the binding of insulin added to the incubating medium. If this situation existed, greater basal and insulin-stimulated 2-deoxy-d-glucose would probably have been observed in the plantaris and EDL. Clearly this was not the case. It therefore seems unlikely that more insulin was stored in these two muscles.
Whatever the mechanism, the present results demonstrate that different types of skeletal muscle with unique biochemical characteristics also differ in their abilities to bind insulin and take up 2-deoxy-d-glucose.
